The effectiveness and cost-effectiveness of seizure dogs
- Conditions
- Refractory epilepsyDrug-resistant epilepsyRefractaire epilepsie Therapieresistente epilepsie
- Registration Number
- NL-OMON26140
- Lead Sponsor
- Erasmus School of Health Policy and Management institute for Medical Technology Assessment
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 35
Inclusion Criteria
Confirmed diagnosis of epilepsy by neurologist with video or EEG confirmation;
- Seizures have to be proven epileptic (exclusion of patients with only or mostly psychogenic non-epileptic seizures);
Exclusion Criteria
- Institutionalized;
- Currently in possession of a trained epilepsy dog;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the study will be seizure frequency.
- Secondary Outcome Measures
Name Time Method Besides the primary outcome measure, the impact of seizure dogs on seizure severity, well-being, health-related quality of life, productivity costs and healthcare resource use (both formal and informal care) will be evaluated.